Patrice Milos
Patrice M. Milos, Ph.D. - Board Member, Senior Advisor, Life Sciences Dr. Patrice Milos is a visionary leader in the field of Precision Health and just completed her tenure at Interim President, of the Rhode Island Life Science Hub and returns to the Hub BOD. In her prior position as Vice President of Scientific Operations at Proof Diagnostics, Inc. (sold to Ginkgo Bioworks, Inc.) Dr. Milos brought her passion of enabling individuals to make informed health decisions through the use of science and novel technology. Patrice oversaw Clinical, Regulatory and Quality for the organization. Dr. Milos co-founded Medley Genomics, a RI startup emerging from Brown University, to deliver novel data analytics for understanding the heterogeneity of complex diseases with a focus in oncology. She also served as Executive Director of the Cherrystone Angel Group. Dr. Milos was CEO of Claritas Genomics, a pediatric molecular diagnostic company spun-out of Boston Children’s Hospital. As Boston Site Head for Pfizer’s Centers of Therapeutic Innovation, Patrice was instrumental in advancing novel therapies to treat human disease. She was also SVP/CSO for Helicos BioSciences in Cambridge, Mass., and Executive Director for Pfizer Inc., responsible for leading a broad platform of genomics supporting precision medicine across the company. In addition to Dr. Milos board role for the RI Life Science Hub, and ProThera Biologics, she serves on the Executive Committee of the RI Bio Board, has previously served on the boards of Slater Technology Fund, SeqLL (NASDAQ: SQL) and is a member of the Brown University Biomedical Innovations to Impact Fund. She’s also senior advisor to several biotech companies including Ribbon Bio and has been an active NIH grant reviewer. Dr. Milos is a member of the Rhode Island Science Technology Advisory Council, RIHub Venture Mentoring Services and has served on the RI Economic Development Planning Council. She earned her M.S./Ph.D. at Rensselaer Polytechnic Institute with postdoctoral fellowships at Brown and Harvard. Patrice lives in Edgewood, RI with her husband and enjoys time sailing Narragansett Bay, skiing and time spent with their two adult children, Henry and Hannah.
RI Life Science Hub, RI Bio, Ribbon Bio
Empowering Breakthroughs: How Synthetic DNA is Redefining Scientific Possibilities
-
Commercial solutions providing synthetic DNA molecules have overcome some of the most challenging manufacturing hurdles, now providing molecules of varying and exceeding length, complexity, and accuracy. These advancements are enabling new possibilities and unlocking vast potential for a range of applications. In this interactive panel, we will bring together leading experts to discuss latest market advancements, innovative approaches utilizing synthetic DNA, and the transformative potential of these solutions.Join us for this discussion as we explore the potential of synthetic DNA and how it can unlock innovations for better health of people and planet.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495